⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XLO News
Xilio Therapeutics, Inc. Common Stock
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
globenewswire.com
XLO
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
globenewswire.com
XLO
Form 8-K
sec.gov
XLO
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
XLO
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
XLO
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XLO
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XLO
Form 8-K
sec.gov
XLO